BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+30.37%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$12B
AUM Growth
+$12B
(+23%)
Cap. Flow
-$219M
Cap. Flow
% of AUM
-1.82%
Top 10 Holdings %
Top 10 Hldgs %
76.74%
Holding
140
New
18
Increased
23
Reduced
51
Closed
10
Top Buys
| 1 |
NVTA
Invitae Corporation
NVTA
|
$110M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$103M |
| 3 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$97.5M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$60.6M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$35.9M |
Top Sells
| 1 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$653M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$73M |
| 3 |
Vanda Pharmaceuticals
VNDA
|
$25.3M |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
$22.9M |
| 5 |
Xoma
XOMA
|
$8.06M |
Sector Composition
| 1 | Healthcare | 40.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCYC
1
DELISTED
PHARMACYCLICS INC
PCYC
| $2.31B | 19.24% | 9,039,652 -89,579 | -1% | -$22.9M |
|
2
Incyte
INCY
$16.5B
| $1.36B | 11.32% | 14,845,559 | – | – |
|
|
GEVA
3
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $1.14B | 9.46% | 11,660,432 +1,000,000 | +9% | +$97.5M |
|
|
SGEN
4
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.02B | 8.49% | 28,876,712 +1,014,992 | +4% | +$35.9M |
|
5
Acadia Pharmaceuticals
ACAD
$4.38B
| $667M | 5.55% | 20,481,442 | – | – |
|
|
6
BioMarin Pharmaceuticals
BMRN
$11.2B
| $523M | 4.35% | 4,200,456 +486,506 | +13% | +$60.6M |
|
|
GHDX
7
DELISTED
Genomic Health, Inc.
GHDX
| $417M | 3.47% | 13,656,942 +624 | +0% | +$19.1K |
|
|
ANAC
8
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $243M | 2.02% | 4,204,702 | – | – |
|
|
NVTA
9
DELISTED
Invitae Corporation
NVTA
| $110M | 0.91% | +6,554,967 | New | +$110M |
|
|
ONCE
10
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $103M | 0.86% | +1,327,451 | New | +$103M |
|
|
DYAX
11
DELISTED
DYAX CORPORATION
DYAX
| $101M | 0.84% | 6,021,485 -136,304 | -2% | -$2.28M |
|
|
BLCM
12
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $97.1M | 0.81% | 4,190,594 -93,138 | -2% | -$2.16M |
|
13
BioCryst Pharmaceuticals
BCRX
$1.74B
| $94.6M | 0.79% | 10,478,204 -235,482 | -2% | -$2.13M |
|
|
MRTX
14
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $82.2M | 0.68% | 2,805,074 +425,000 | +18% | +$12.5M |
|
15
Cerus
CERS
$251M
| $56.5M | 0.47% | 13,553,275 +1,850,548 | +16% | +$7.72M |
|
|
ARAV
16
DELISTED
Aravive, Inc. Common Stock
ARAV
| $54.7M | 0.45% | 2,977,396 +695,652 | +30% | +$12.8M |
|
|
17
Xoma
XOMA
$392M
| $53.5M | 0.45% | 14,708,613 -2,215,400 | -13% | -$8.06M |
|
|
XNPT
18
DELISTED
XENOPORT, INC.
XNPT
| $46.3M | 0.39% | 6,508,622 -395,006 | -6% | -$2.81M |
|
|
ARRY
19
DELISTED
Array Biopharma Inc
ARRY
| $41.7M | 0.35% | 5,658,755 +4,224,958 | +295% | +$31.1M |
|
20
Heron Therapeutics
HRTX
$207M
| $37.9M | 0.32% | 2,607,784 | – | – |
|
|
DBVT
21
DBV Technologies
DBVT
$264M
| $35.5M | 0.3% | 1,519,229 | – | – |
|
22
Insmed
INSM
$28.8B
| $32.9M | 0.27% | 1,583,490 +475,640 | +43% | +$9.89M |
|
23
Catalyst Pharmaceutical
CPRX
$2.52B
| $32.8M | 0.27% | 7,565,462 +850,000 | +13% | +$3.68M |
|
24
Halozyme
HALO
$8.56B
| $32.1M | 0.27% | 2,248,152 -527,991 | -19% | -$7.54M |
|
25
TG Therapeutics
TGTX
$4.65B
| $31.7M | 0.26% | 2,050,313 | – | – |
|